Company Directory - Tilray Brands, Inc.
Company Details - Tilray Brands, Inc.

Tilray Brands, Inc.
WebsiteNanaimo, Canada
Tilray Brands, Inc. is a global leader in cannabis research, cultivation, and distribution, providing high-quality cannabis products across various markets and geographies.
CCI Score
CCI Score: Tilray Brands, Inc.
2.14
Latest Event
Tilray Brands Lobbying Registration Filing
Tilray Brands, Inc. appears in the U.S. House Lobbying Disclosure database as a registrant, indicating its active involvement in political lobbying efforts. This registration underscores the company's engagement in influencing policy through established lobbying channels.
Take Action
So what can you do? Support Tilray by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
Tilray Brands, Inc. is currently rated as an Objector.
Latest Events
- JAN012025
Tilray Brands, Inc. appears in the U.S. House Lobbying Disclosure database as a registrant, indicating its active involvement in political lobbying efforts. This registration underscores the company's engagement in influencing policy through established lobbying channels.
-30
Political Contributions and Lobbying Efforts
April 8
Tilray Brands, Inc.'s listing in the official lobbying disclosure system signals its participation in direct political lobbying. From an anti-fascist perspective, such corporate involvement in policy influence is concerning, as it can contribute to the broader problem of oligarchic influence, potentially undermining democratic governance and favoring authoritarian-friendly policies.
- NOV012024
On November 1, 2024, a lawsuit was filed alleging that Tilray Brands Inc. attempted for a second consecutive year to trick investors into approving an increase in its share limit by misrepresenting the provisions of its corporate charter.
-50
Business Practices and Ethical Responsibility
April 8
The lawsuit claims that Tilray engaged in deceptive tactics to mislead shareholders about the proper voting requirements for increasing the share limit. This behavior undermines corporate transparency, deviates from ethical business practices, and can erode investor trust, thus contributing negatively from a corporate accountability perspective.
Cannabis Company Tilray Sued Over Vote to Increase Share Limit
- OCT112024
Tilray CEO and chairman Irwin D. Simon expressed optimism that the upcoming U.S. presidential election may lead to regulatory changes favoring cannabis legalization. Concurrently, Tilray launched its Tilray Alternative Beverages unit with new hemp-derived THC drinks across key U.S. markets, signaling a strategic move to capitalize on progressive political shifts.
+40
Executive Political Engagement
April 8
The CEO's optimistic commentary about potential regulatory changes in cannabis legalization following the U.S. presidential election indicates proactive executive political engagement. This stance aligns with progressive trends toward decriminalization and market liberalization, supporting broader anti-authoritarian and consumer empowerment initiatives.
Tilray CEO optimistic about cannabis legalization after election
- OCT102024
Tilray CEO Irwin Simon indicated that the upcoming 2024 U.S. Presidential election is expected to result in improved regulatory conditions for the cannabis industry, a change that could contribute to progressive reforms by reducing punitive drug policies historically affecting marginalized communities.
+50
Executive Political Engagement
April 8
The CEO's public statement reflects executive political engagement by anticipating regulatory improvements driven by the election outcome. This stance is viewed positively as it supports the advancement of cannabis legalization, which aligns with efforts to reduce historically harmful punitive measures that have disproportionately affected marginalized groups.
Tilray CEO Bullish on Cannabis Legalization Following 2024 Election
Alternatives

Chandler, USA
26.15

Corporation
54.50

Bagsværd, Denmark
18.81

Irving, United States
-17.26

Alwar, India
-35.16

Deerfield, United States
-40.16
Woonsocket, USA
-46.49
Corporation
49.05

Nowshera,
0.00

Corporation
0.00
Corporate Financials
- Revenue
- 2025
- $400.00M
- Total Assets
- 2025
- $1.80B
- Operating Income
- 2025
- -$50.00M
- Total Equity
- 2025
- $1.00B
Industries
- 311920
- Coffee and Tea Manufacturing
- 325411
- Medicinal and Botanical Manufacturing
- 424210
- Drugs and Druggists' Sundries Merchant Wholesalers
- 446110
- Pharmacies and Drug Stores
- 111420
- Tobacco Seed Farming